Optimized Caloric-proteic Nutrition in Critically Ill Patients

Sponsor
Hospital Sao Domingos (Other)
Overall Status
Completed
CT.gov ID
NCT03060668
Collaborator
(none)
138
1
2
30
4.6

Study Details

Study Description

Brief Summary

In this prospective randomized controlled trial the investigators intend to compare the use of a nutritional therapy based on caloric intake determined by indirect calorimetry and a high protein intake (2.0 to 2.2 g/kg/day) with a nutritional regimen based on 25 Kcal/kg/day and protein intake usually recommended to critically ill patients (1.4 to 1.5 grams/kg/day).

Condition or Disease Intervention/Treatment Phase
  • Other: Peptamen intense
  • Other: Novasource senior
N/A

Detailed Description

OBJECTIVES

To evaluate the effect of nutritional therapy with caloric intake determined by indirect calorimetry and high protein intake (2.0 to 2.2 g/kg/day) compared to nutritional therapy with 25 kcal/kg/day and 1.4 to 1, 5 g/kg/day of protein on short-term outcomes and physical component (PCS) of quality of life after 3 and 6 months of randomization in severe ICU patients.

The primary objective will be the evaluation of the physical component summary (PCS) of SF-36 (Short Form 36), a questionnaire used to evaluate quality of life, validated for the Brazilian population. Patients will be assessed at least 3 and 6 months after randomization.

Secondary objectives: Measurement of handgrip strength measured on the 7th and 14th day of the study and on discharge from the ICU, ICU mortality, hospital mortality, mechanical ventilation time and length of stay in the ICU.

METHODS

The study will include patients over 18 years of age, not pregnant, submitted to mechanical ventilation, whose expectation of stay in the ICU is greater than 3 days.

The sample size was calculated based on the following parameters: patient population under mechanical ventilation, 528, 15% relative risk reduction in the evaluation parameter of the SF-36 tool, Level of significance (α) of 5%, test power of 80%, thus the number of individuals to be sampled will be 294, i.e., two groups of 147 patients. A computer-generated list for randomization and sequentially numbered opaque sealed envelopes is used. The level of significance to reject the null hypothesis will be 5%, that is, a value of p <0.05 will be considered as statistically significant.

Informed consent was obtained from the patient or a next of kin.

Study Design

Study Type:
Interventional
Actual Enrollment :
138 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Optimized Caloric-proteic Nutrition in Critically Ill Patients: Impact on Short and Long-term Outcomes
Actual Study Start Date :
Jun 1, 2016
Actual Primary Completion Date :
May 1, 2018
Actual Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study Group

Caloric needs will be determined by indirect calorimetry. Patients in this group will receive 2.0 to 2.2 grams/kg/day of protein. Nutritional therapy will be initiated in the first 24 hours after admission. Nutritional formula will be Peptamen Intense (1.0 kcal/ml, 93 g/L protein (Nestle Health Care).

Other: Peptamen intense
Study group will receive a nutritional formula containing 1.0 kcal/ml and 93 g/L of protein

Active Comparator: Control Group

Patients in this group will receive 25 Kcal/kg/day and 1.4 to 1.5 grams/kg/day of protein. Nutritional formula in this group will be Novasource senior (Nestle Health Care). Nutritional therapy will be initiated in the first 24 hours after admission.

Other: Novasource senior
Control group will receive a nutritional formula containing 1.2 kcal/ml and 65 g/L of protein

Outcome Measures

Primary Outcome Measures

  1. PCS of SF-36 [6 months after randomization]

    Physical component summary of Short Form 36

Secondary Outcome Measures

  1. Handgrip strength [7th, 14th after admission and up to 30 days]

    Measured using a calibrated dynamometer

  2. ICU mortality [Up to 30 days]

    ICU outcome

  3. Hospital mortality [Up to 6 months]

    Hospital outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Critically ill patients Mechanically ventilated Expected length in the ICU > 3 days
Exclusion Criteria:
  • Pregnancy Requirement for inspired oxygen (FIO2) > 0.60 High output bronchopleural fistula

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Sao Domingos Sao Luis MA Brazil 65060-000

Sponsors and Collaborators

  • Hospital Sao Domingos

Investigators

  • Principal Investigator: JOSE R AZEVEDO, PhD, Hospital Sao Domingos

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
José Raimundo Araujo de Azevedo, PhD, Hospital Sao Domingos
ClinicalTrials.gov Identifier:
NCT03060668
Other Study ID Numbers:
  • HSaoDomingos
First Posted:
Feb 23, 2017
Last Update Posted:
Mar 16, 2022
Last Verified:
Feb 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by José Raimundo Araujo de Azevedo, PhD, Hospital Sao Domingos
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2022